Matt Larson has over 20 years of experience in the ophthalmic sector. With roles on the clinical research side as well as several positions with a commercial focus, Matt has been involved in multiple aspects of medical device companies. He has led product launches in the US, Asia Pacific, and Europe, and played an executive role in guiding multiple new products through U.S. FDA approval.  Matt has raised more than $40M across multiple ophthalmology startups and held multiple CEO positions. He is a partner in an ophthalmic-focused investment fund that has deployed approximately $200M across multiple companies. He also serves as a member of the board of directors for various companies.